Weight Loss Benefits of Rifaximin in an Intermittent Fasting Diet
Clinical trial NCT04674176 · UNKNOWN
Trial details
- NCT number
- NCT04674176
- Sponsor
- Bayhealth Medical Center
- Status
- UNKNOWN
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2021-01-01
- Primary completion
- 2022-01-01
- Enrollment
- 30
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.